NEW YORK (GenomeWeb) – Parent Project Muscular Dystrophy today announced it has granted $250,000 to University of Texas Southwestern Medical Center researcher Eric Olson for his study of a CRISPR/Cas9-based treatment for Duchenne muscular dystrophy (DMD).

Olson said in a statement that he would use the funding to test the effectiveness and safety of CRISPR in animal models of DMD. The lab will study dystrophin proteins produced using genome editing in mice and compare them to dystrophin produced by other therapeutic approaches, such as gene transfer.